<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38097277</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>152</Volume><PubDate><Year>2023</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>Epidemiology and infection</Title><ISOAbbreviation>Epidemiol Infect</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 neuropsychiatric manifestations: a suggested therapeutic approach to 'long COVID' with azithromycin.</ArticleTitle><Pagination><StartPage>e34</StartPage><MedlinePgn>e34</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e34</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268823001966</ELocationID><Abstract><AbstractText>The devastating effects of the coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may not end when the acute illness has terminated. A subset of COVID-19 patients may have symptoms that persist for months. This condition has been described as 'long COVID'. From a historical perspective, it has been recognized that serious long-term neurological sequelae have been associated with RNA viruses such as influenza viruses and coronaviruses. A potential intervention for early post-COVID-19 neuropsychiatric impairment may be the commonly employed, readily available, reasonably priced macrolide antibiotic, azithromycin. We have observed a favourable clinical response with azithromycin in three patients with neurological symptoms associated with long COVID-19. We recommend considering formal clinical trials using azithromycin for patients with post-COVID-19 infection neurological changes including 'COVID fog' or the more severe neurological symptoms that may later develop.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-3036-3825</Identifier><AffiliationInfo><Affiliation>Rutgers New Jersey Medical School, Newark, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suskind</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>California University of Science and Medicine, Colton, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Infect</MedlineTA><NlmUniqueID>8703737</NlmUniqueID><ISSNLinking>0950-2688</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="Y">Azithromycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Kapila syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">azithromycin</Keyword><Keyword MajorTopicYN="N">encephalitis</Keyword><Keyword MajorTopicYN="N">macrolide</Keyword><Keyword MajorTopicYN="N">von Economo disease</Keyword></KeywordList><CoiStatement>The authors declare none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>15</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>14</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38097277</ArticleId><ArticleId IdType="pmc">PMC10894889</ArticleId><ArticleId IdType="doi">10.1017/S0950268823001966</ArticleId><ArticleId IdType="pii">S0950268823001966</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schwartz RA, Kapila R (2021). Pandemics throughout the centuries. Clinics in Dermatology 39(1),5&#x2013;8. 10.1016/j.clindermatol.2020.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clindermatol.2020.12.006</ArticleId><ArticleId IdType="pubmed">33972052</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi N, Schwartz RA (2020). COVID-19 with dermatologic manifestations and implications: an unfolding conundrum. Dermatologic Therapy 9, e13544. 10.1111/dth.13544</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.13544</ArticleId><ArticleId IdType="pmc">PMC7261983</ArticleId><ArticleId IdType="pubmed">32385869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapila CC, et al. (1958). Neurological and hepatic disorders associated with influenza. British Medical Journal 2, 1311&#x2013;1314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2027345</ArticleId><ArticleId IdType="pubmed">13596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, et al. (2021). Long covid-mechanisms, risk factors, and management. British Medical Journal 374, n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer EA, Kohn JN, Hong S (2020). Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain, Behavior, and Immunogy 87, 34&#x2013;39. 10.1016/j.bbi.2020.04.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, et al. (2017). Neurological complications during treatment of Middle East respiratory syndrome. Journal of Clinical Neurology 13(3), 227&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5532318</ArticleId><ArticleId IdType="pubmed">28748673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai LK, Hsieh ST, Chang YC (2005). Neurological manifestations in severe acute respiratory syndrome. Acta Neurologica Taiwanica 14(3), 113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">16252612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, et al. (2020). Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behavior, and Immunogy 87, 18&#x2013;22. 10.1016/j.bbi.2020.03.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller E (2022). Neuro-COVID-19: Neurological Complications of COVID-19 (Neuro-COVID). Available at https://clinicaltrials.gov/ct2/show/NCT04418609 (accessed 12 July 2023).</Citation></Reference><Reference><Citation>Collins FS (2021). NIH launches new initiative to study &#x201c;Long COVID&#x201d;. Available at https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid (accessed 12 July 2023).</Citation></Reference><Reference><Citation>Schwartz RA, Suskind RM (2020). Azithromycin and COVID-19: prompt early use at first signs of this infection in adults and children, an approach worthy of consideration. Dermatologic Therapy 33(4), e13785. 10.1111/dth.13785</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.13785</ArticleId><ArticleId IdType="pmc">PMC7300563</ArticleId><ArticleId IdType="pubmed">32510734</ArticleId></ArticleIdList></Reference><Reference><Citation>https://clinicaltrials.gov/ct2/results?cond=COVID-19&amp;term=azithromycin&amp;cntry=US&amp;state=&amp;city=&amp;dist= (accessed 12 July 2023).</Citation></Reference><Reference><Citation>Janniger EJ, Kapila R (2021). Public health issues with Candida auris in COVID-19 patients. World Medical &amp; Health Policy 13(4), 766&#x2013;772. 10.1002/wmh3.472</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wmh3.472</ArticleId><ArticleId IdType="pmc">PMC8661744</ArticleId><ArticleId IdType="pubmed">34909239</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB (2021). Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Frontiers in Microbiology 12, 698169. 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert WC, et al. (2021). What we have learned from the COVID-19 pandemic: time to think outside the box, maybe far outside. Clinics in Dermatology 39, 101&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834261</ArticleId><ArticleId IdType="pubmed">33972037</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousafzai ADK, et al. (2023). Clinical efficacy of Azithromycin for COVID-19 management: a systematic meta-analysis of meta-analyses. Heart &amp; Lung 60, 127&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10017380</ArticleId><ArticleId IdType="pubmed">36996755</ArticleId></ArticleIdList></Reference><Reference><Citation>Golchin Vafa R, et al. (2023). The long-term effects of the Covid-19 infection on cardiac symptoms. BMC Cardiovascular Disorders 23(1), 286. 10.1186/s12872-023-03322-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-023-03322-8</ArticleId><ArticleId IdType="pmc">PMC10243271</ArticleId><ArticleId IdType="pubmed">37280530</ArticleId></ArticleIdList></Reference><Reference><Citation>Popp M, et al. (2021). Antibiotics for the treatment of COVID-19.&#xa0;Cochrane Database of Systematic Reviews 10(10), CD015025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536098</ArticleId><ArticleId IdType="pubmed">34679203</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleyzac N, et al. (2020). Azithromycin for COVID-19: more than just an antimicrobial? Clinical Drug Investigation 40(8), 683&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290142</ArticleId><ArticleId IdType="pubmed">32533455</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, et al. (2023). A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: a call to action for neurological, physical, and psychological sciences. Journal of Medical Virology 95(6), e28852. 10.1002/jmv.28852</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28852</ArticleId><ArticleId IdType="pubmed">37288652</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>